Effect of Loratadine in Lymphangioleiomyomatosis
Clinical trial NCT05190627 · UNKNOWN
Trial details
- NCT number
- NCT05190627
- Sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2022-12-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.